Video Experimental Relacionado
Updated: Jan 8, 2026

06:03
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
18.0K
CD26 como una posible diana terapéutica para el adenocarcinoma de pulmón
Wolfgang Jungraithmayr1,2,3, Birte Ohm2, Martina Haberecker4
1Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Frontiers in oncology
|December 22, 2025
Resumen
La expresión de CD26 (dipeptidil peptidasa 4) se correlaciona con una mejor supervivencia en el cáncer de pulmón de células no pequeñas, particularmente en el adenocarcinoma. La inhibición de CD26 redujo el crecimiento de las células tumorales y los marcadores de EMT in vitro, lo que sugiere un potencial terapéutico.
Más Videos Relacionados
Videos de Conceptos Relacionados
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

